Tefron Ltd.
TFRFF
$7.34
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 292.26M | 277.11M | 264.08M | 243.46M | 244.28M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 292.26M | 277.11M | 264.08M | 243.46M | 244.28M |
| Cost of Revenue | 225.14M | 213.93M | 204.04M | 188.32M | 188.93M |
| Gross Profit | 67.12M | 63.18M | 60.04M | 55.14M | 55.35M |
| SG&A Expenses | 34.80M | 32.41M | 31.22M | 29.90M | 30.34M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 266.88M | 252.82M | 241.36M | 223.92M | 224.82M |
| Operating Income | 25.38M | 24.29M | 22.72M | 19.54M | 19.46M |
| Income Before Tax | 20.75M | 19.49M | 17.88M | 14.46M | 13.85M |
| Income Tax Expenses | 4.81M | 4.58M | 4.51M | 3.52M | 3.58M |
| Earnings from Continuing Operations | 15.94 | 14.91 | 13.38 | 10.93 | 10.28 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15.94M | 14.91M | 13.38M | 10.93M | 10.28M |
| EBIT | 25.38M | 24.29M | 22.72M | 19.54M | 19.46M |
| EBITDA | 32.78M | 31.45M | 29.39M | 25.83M | 25.33M |
| EPS Basic | 1.28 | 1.20 | 1.09 | 0.89 | 0.82 |
| Normalized Basic EPS | 1.04 | 0.98 | 0.91 | 0.73 | 0.69 |
| EPS Diluted | 1.19 | 1.13 | 1.03 | 0.85 | 0.80 |
| Normalized Diluted EPS | 0.97 | 0.92 | 0.86 | 0.70 | 0.68 |
| Average Basic Shares Outstanding | 49.83M | 49.72M | 49.25M | 49.36M | 49.94M |
| Average Diluted Shares Outstanding | 53.74M | 52.93M | 52.22M | 51.59M | 51.05M |
| Dividend Per Share | 0.16 | 0.16 | 0.16 | 0.16 | -- |
| Payout Ratio | 12.52% | 13.38% | -- | -- | -- |